articles
phosphoramidate pronucleotides: a comparison of the
phosphoramidase substrate specificity of human and
escherichia coli histidine triad nucleotide binding proteins
tsui-fen chou,â€  janina baraniak,â€¡ renata kaczmarek,â€¡ xin zhou,â€  jilin cheng,â€ 
brahma ghosh,â€  and carston r. wagner*,â€ ,Â§
departments of medicinal chemistry and chemistry, university of minnesota, minneapolis,
minnesota 55455, and department of bioorganic chemistry, centre of molecular and
macromolecular studies, polish academy of science, lodz, poland
received june 23, 2006; revised manuscript received october 19, 2006; accepted october 26, 2006

abstract: to facilitate the delivery of nucleotide-based therapeutics to cells and tissues, a variety of
pronucleotide approaches have been developed. our laboratory and others have demonstrated that
nucleoside phosphoramidates can be activated intracellularly to the corresponding 5â€²-monophosphate
nucleotide and that histidine triad nucleotide binding proteins (hints) are potentially responsible for their
bioactivation. hints are conserved and ubiquitous enzymes that hydrolyze phosphoramidate bonds
between nucleoside 5â€²-monophosphate and an amine leaving group. on the basis of the ability of
nucleosides to quench the fluorescence of covalently linked amines containing indole, a sensitive, continuous fluorescence-based assay was developed. a series of substrates linking the naturally fluorogenic
indole derivatives to nucleoside 5â€²-monophosphates were synthesized, and their steady state kinetic
parameters of hydrolysis by human  xxxg1050xxx  and escherichia coli hint were evaluated. to characterize the
elemental and stereochemical effect on the reaction, two p-diastereoisomers of adenosine or guanosine
phosphoramidothioates were synthesized and studied to reveal a 15-200-fold decrease in the specificity
constant (kcat/km) when the phosphoryl oxygen is replaced with sulfur. while a stereochemical preference
was not observed for e. coli hint, hhint1 exhibited  xxxd3426xxx -fold preference for  xxxd1794xxx  phosphoramidates over l-isomers. the most efficient substrates evaluated to date are those that contain the less
sterically hindering amine leaving group, tryptamine, with kcat and km values comparable to those found
for  xxxg79xxx . the apparent second-order rate constants (kcat/km) for adenosine tryptamine
phosphoramidate monoester were found to be 107 m-1 s-1 for hhint1 and 106 m-1 s-1 for e. coli hint.
both the human and e. coli enzymes preferred purine over pyrimidine analogues. consistent with observed
hydrogen bonding between the 2â€²-oh group of  xxxd81xxx  and the active site residue,
asp43, the second-order rate constant (kcat/km) for thymidine tryptamine phosphoramidate was found to
be 3-4 orders of magnitude smaller than that for uridine tryptamine phosphoramidate for hhint1 and 2
orders of magnitude smaller than that for e. coli hint. ara-a tryptamine phosphoramidate was, however,
shown to be a good substrate with a specificity constant (kcat/km) only 10-fold lower than the value for
adenosine tryptamine phosphoramidate. consequently, nucleoside phosphoramidates containing unhindered primary amines and either an r or beta 2â€²-oh group should be easily bioactivated by hints with
efficiencies rivaling those for the 5â€²-monophosphorylation of nucleosides by nucleoside kinases. the
differential substrate specificity observed for human and e. coli enzymes represents a potential therapeutic
rationale for the development of selective antibiotic phosphoramidate pronucleotides.
keywords: histidine triad nucleotide binding proteins (hints); phosphoramidase; human  xxxg1050xxx ;
escherichia coli hint; fluorogenic phosphoramidates

introduction
nucleosides are an important class of therapeutics. in
particular, nucleosides have been clinically used for decades
* to whom correspondence should be addressed: department of
medicinal chemistry, university of minnesota, 8-174 weaver
densford hall, 308 harvard st. se, minneapolis, mn 55455.
phone: (612) 625-2614. fax: (612) 624-0139. e-mail:
wagne003@umn.edu.
â€  department of medicinal chemistry, university of minnesota.
â€¡ polish academy of science.
Â§ department of chemistry, university of minnesota.
208

molecular pharmaceutics vol. 4, no. 2, 208-217

as both antiviral and anticancer drugs. unfortunately, because
they typically must be converted by intracellular kinases to
the corresponding 5â€²-mono-, di-, and triphosphate, the utility
of a given nucleoside will depend on the substrate specificity
of these intracellular enzymes. since in general the substrate
requirements for nucleoside kinases are more demanding than
for either nucleotidylate or diphosphosphate kinases, a
method of delivering nucleoside 5â€²-monophosphates would
expand the number of potentially therapeutically useful
nucleosides. to address this issue, a number of imaginative
pronucleotide approaches have been developed.1 in general,
10.1021/mp060070y ccc: $37.00 Â© 2007 american chemical society
published on web 01/12/2007

phosphoramidate pronucleotides
these methods rely on either remote chemical or enzymatic
activation of the masking moiety, followed by collapse of
an unstable intermediate and release of the nucleotide. early
efforts to design phosphate ester pronucleotides were limited
in their success. our laboratory and others have sought to
utilize phosphoramidate esters as possible pronucleotides.2-8
recently, direct intracellular p-n bond cleavage has been
observed by esi-ms for azt l-tryptophan phosphoramidate
monoesters.9 moreover, we have demonstrated that human
and bacterial variants of a subfamily of the histidine triad
(hit) protein superfamily are nucleoside phosphoramidases.10
hit enzymes are a ubiquitous superfamily consisting
primarily of nucleoside phosphoramidases, dinucleotide
hydrolyases, and nucleotidylyl transferases.11 the distinguishing feature of these enzymes is an active site motif
(1) wagner, c. r.; iyer, v. v.; mcintee, e. j. pronucleotides: toward
the in vivo delivery of antiviral and anticancer nucleotides. med.
res. rev. 2000, 20, 417-451.
(2) abraham, t. w.; mcintee, e. j.; vidhya, v. i.; schinazi, r. f.;
wagner, c. r. synthesis and biological activity and decomposition
studies of amino acid phosphomonoester amidates of acyclovir.
nucleosides, nucleotides nucleic acids 1997, 16, 2079-2092.
(3) mcintee, e. j.; remmel, r. p.; schinazi, r. f.; abraham, t. w.;
wagner, c. r. probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral
nucleoside prodrugs. j. med. chem. 1997, 40, 3323-3331.
(4) chang, s. l.; griesgraber, g. w.; southern, p. j.; wagner, c. r.
amino acid phosphoramidate monoesters of 3â€²-azido-3â€²- xxxd3364xxx : relationship between antiviral potency and intracellular metabolism. j. med. chem. 2001, 44, 223-231.
(5) chang, s. l.; griesgraber, g. w.; wagner, c. r. comparison of
the antiviral activity of hydrophobic amino acid phosphoramidate
monoesters of 2â€²,3â€²- xxxd929xxx  (dda) and 3â€²-azido-3â€² xxxd3364xxx  (azt). nucleosides, nucleotides nucleic acids
2001, 20, 1571-1582.
(6) mcguigan, c.; harris, s. a.; daluge, s. m.; gudmundsson, k.
s.; mclean, e. w.; burnette, t. c.; marr, h.; hazen, r.;
condreay, l. d.; johnson, l.; de clercq, e.; balzarini, j.
application of phosphoramidate pronucleotide technology to
abacavir leads to a significant enhancement of antiviral potency.
j. med. chem. 2005, 48, 3504-3515.
(7) mcguigan, c.; cahard, d.; sheeka, h. m.; de clercq, e.;
balzarini, j. phosphoramidate derivatives of d4t with improved
anti-hiv efficacy retain full activity in thymidine kinase-deficient
cell. bioorg. med. chem. lett. 1996, 6, 1183-1186.
(8) meier, c.; balzarini, j. application of the cyclosal-prodrug
approach for improving the biological potential of phosphorylated
biomolecules. antiviral res. 2006, 71, 282-292.
(9) kim, j.; chou, t.-f.; griesgraber, g. w.; wagner, c. r. direct
measurement of nucleoside monophosphate delivery from a
phosphoramidate pronucleotide by stable isotope labeling and lcesi-ms/ms. mol. pharmaceutics 2004, 1, 102-111.
(10) chou, t.-f.; bieganowski, p.; shilinski, k.; cheng, j.; brenner,
c.; wagner, c. r. 31p nmr and genetic analysis establish hint
as the only escherchia coli  xxxd2705xxx  phosphoramidase
and as essential for growth under high salt conditions. j. biol.
chem. 2005, 280, 15356-15361.
(11) brenner, c. hint,  xxxg797xxx , and galt: function, structure, evolution,
and mechanism of three branches of the histidine triad superfamily
of nucleotide hydrolases and transferases. biochemistry 2002, 41,
9003-9014.

articles
composed of the sequence his-x-his-x-his-xx, where x
is a hydrophobic residue. three primary hit families have
been identified. the first and most ancient is the family of
the histidine triad nucleotide binding protein (hint). hint
homologues isolated from rabbits,12 humans,10 chickens,13
yeast,12 and escherichia coli10 have been shown to be purine
nucleoside phosphoramidases. mammalian  xxxg1050xxx  has been
suggested to have tumor suppressor activity in a hint1knockout mice model14,15 and human non-small cell lung
carcinoma cells.16 related to this observation, the expression
of hhint1 has been shown to be a potential regulator of
apoptosis.17 nevertheless, the cellular function and biochemical relevance of the phosphoramidase activity have remained
a mystery. two less typical members of the hint family are
aprataxin, which is mutated in ataxia-oculomotor apraxia1,18,19 and the scavenger  xxxg613xxx , dcps/
 xxxg613xxx , a 7-methyl gpppg hydrolyase.20,21 the second family
is that of the  xxxg797xxx  ( xxxg797xxx ), which exhibits
characteristic diadenosine polyphosphate hydrolase activity
(12) bieganowski, p.; garrison, p. n.; hodawadekar, s. c.; faye, g.;
barnes, l. d.; brenner, c. adenosine monophosphoramidase
activity of hint and hnt1 supports function of kin28, ccl1, and
tfb3. j. biol. chem. 2002, 277, 10852-10860.
(13) parks, k. p.; seidle, h.; wright, n.; sperry, j. b.; bieganowski,
p.; howitz, k.; wright, d. l.; brenner, c. altered specificity of
hint-w123q supports a role for hint inhibition by asw in avian
sex determination. physiol. genomics 2004, 20, 12-14.
(14) su, t.; suzui, m.; wang, l.; lin, c. s.; xing, w. q.; weinstein,
i. b. deletion of  xxxg1050xxx /pkcinteracting protein in mice enhances cell growth and carcinogenesis. proc. natl. acad. sci. u.s.a. 2003, 100, 7824-7829.
(15) li, h.; zhang, y.; su, t.; santella, r. m.; weinstein, i. b.  xxxg1050xxx 
is a haplo-insufficient tumor suppressor in mice. oncogene 2006,
25, 713-721.
(16) yuan, b. z.; jefferson, a. m.; popescu, n. c.; reynolds, s. h.
aberrant gene expression in human non small cell lung carcinoma
cells exposed to demethylating agent 5-aza-2â€²- xxxd1836xxx .
neoplasia 2004, 6, 412-429.
(17) weiske, j.; huber, o. the histidine triad protein  xxxg1050xxx  triggers
apoptosis independent of its enzymatic activity. j. biol. chem.
2006, 281, 27356-27366.
(18) moreira, m. c.; barbot, c.; tachi, n.; kozuka, n.; uchida, e.;
gibson, t.; mendonca, p.; costa, m.; barros, j.; yanagisawa,
t.; watanabe, m.; ikeda, y.; aoki, m.; nagata, t.; coutinho, p.;
sequeiros, j.; koenig, m. the gene mutated in ataxia-ocular
apraxia 1 encodes the new hit/zn-finger protein aprataxin. nat.
genet. 2001, 29, 189-193.
(19) date, h.; onodera, o.; tanaka, h.; iwabuchi, k.; uekawa, k.;
igarashi, s.; koike, r.; hiroi, t.; yuasa, t.; awaya, y.; sakai,
t.; takahashi, t.; nagatomo, h.; sekijima, y.; kawachi, i.;
takiyama, y.; nishizawa, m.; fukuhara, n.; saito, k.; sugano,
s.; tsuji, s. early-onset ataxia with ocular motor apraxia and
hypoalbuminemia is caused by mutations in a new hit superfamily gene. nat. genet. 2001, 29, 184-188.
(20) liu, h.; rodgers, n. d.; jiao, x.; kiledjian, m. the scavenger
 xxxg613xxx  dcps is a member of the hit family
of pyrophosphatases. embo j. 2002, 21, 4699-4708.
(21) kwasnicka, d. a.; krakowiak, a.; thacker, c.; brenner, c.;
vincent, s. r. coordinate expression of nadph-dependent flavin
reductase, fre-1, and  xxxg613xxx ,
 xxxg613xxx . j. biol. chem. 2003, 278, 39051-39058.
vol. 4, no. 2 molecular pharmaceutics

209

articles
and was reported to possess tumor suppressor activity.22 the
third family contains relatives of galactose-1-phosphate
uridylyltransferase (galt), which is a specific nucleoside
monophosphate transferase.23
the reaction mechanism of the hint protein family has
been proposed to be a two-step double replacement, in which
the complex of a phosphoramidate with his112 of hhint1
or his101 of e. coli hint forms a covalent hint-nmp
intermediate (n is a or g) followed by dissociation of the
amine. in the second step, the hint-nmp intermediate
undergoes hydrolysis to release nmp and hint. the mechanism is inspired by the similarities of hint proteins to fhit24
and galt.25 recently, human  xxxg797xxx  has been shown to possess
phosphoramidase activity with adenosine 5â€²-phosphoimidazolide (amp-im) and adenosine 5â€²-phospho-n-methylimidazolide (amp-n-meim) as substrates with similar catalytic
efficiencies in comparison with its best substrate p1-5â€²-oadenosine-p3-5â€²-o- xxxd83xxx  (ap3a).24,26 the
only reported spectroscopic substrate of hint, adenosine 5â€²o-p-nitrophenylphosphoramidate (amp-pna), has relatively
poor michaelis-menten parameters (kcat ) 0.00187 s-1, km
) 134, and kcat/km ) 14 s-1 m-1).27 other reported methods
for detecting hint-catalyzed reaction are either a complicated coupled assay that can detect only formation of
amp24 or a discontinuous and labor-intensive hplc or tlc
assay.12,27
in this study, we report the development of a continuous
fluorescence-based assay for hint phosphoramidase activity,
which we then used to map the substrate specificity for the
human and bacterial enzymes. on the basis of these results,
we propose a set of parameters for the design of hint
activatible phosphoramidate pronucleotides.
(22) ohta, m.; inoue, h.; cotticelli, m. g.; kastury, k.; baffa, r.;
palazzo, j.; siprashvili, z.; mori, m.; mccue, p.; druck, t.; croce,
c. m.; huebner, k. the  xxxg797xxx  gene, spanning the chromosome
3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. cell 1996, 84, 587597.
(23) frey, p. a.; wong, l. j.; sheu, k. f.; yang, s. l. galactose-1phosphate uridylyltransferase: detection, isolation, and characterization of the uridylyl enzyme. methods enzymol. 1982, 87,
20-36.
(24) huang, k.; arabshahi, a.; wei, y.; frey, p. a. the mechanism
of action of the  xxxg797xxx ,  xxxg797xxx : isolation of a covalent
adenylyl enzyme and chemical rescue of h96g- xxxg797xxx . biochemistry
2004, 43, 7637-7642.
(25) wedekind, j. e.; frey, p. a.; rayment, i. the structure of
nucleotidylated histidine-166 of galactose-1-phosphate uridylyltransferase provides insight into phosphoryl group transfer.
biochemistry 1996, 35, 11560-11569.
(26) huang, k.; arabshahi, a.; frey, p. a. ph-dependence in the
hydrolytic action of the human  xxxg797xxx . eur. j. org.
chem. 2005, 5198-5206.
(27) krakowiak, a.; pace, h. c.; blackburn, g. m.; adams, m.;
mekhalfia, a.; kaczmarek, r.; baraniak, j.; stec, w. j.; brenner,
c. biochemical, crystallographic, and mutagenic characterization
of hint, the amp-lysine hydrolase, with novel substrates and
inhibitors. j. biol. chem. 2004, 279, 18711-18716.
210

molecular pharmaceutics vol. 4, no. 2

chou et al.

experimental procedures
general synthetic procedure for fluorogenic nucleoside 5â€²-phosphoramidates. nucleoside 5â€²-phosphoramidates
were prepared in a single-step carbodiimide-mediated coupling reaction as described previously10 with minor modification.
1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride (4.5 equiv) was added to a solution of nucleoside
5â€²-monophosphate (1 equiv) and indole compound (5 equiv)
in h2o (ph âˆ¼7.0, adjusted with sodium hydroxide) at room
temperature for 6 h and concentrated under reduced pressure.
the resulting solid was then purified by flash chromatography (sio2, 5:3:0.5 chcl3/meoh/h2o mixture containing
0.5% nh4oh) to give the desired products. for some
tryptamine analogues, the preparative hplc purification was
carried out using an alltech econosphere c8 column (10
mm Ã— 250 mm) with a linear gradient elution of solvent a
(hplc-grade water) and solvent b (hplc-grade methanol)
at a flow rate of 3 ml/min. the gradient is as follows: 0%
b for 2 min, from 0 to 5% b from 2 to 12 min, and from 5
to 100% b from 12 to 16 min. the elution peak at 6-7 min
was collected to give the white solid.
2(s)-[adenosyl-5â€²-(phosphorylamino)]-3-(3-indolyl)proprionic acid methyl ester (1). the yield is 62.7% (0.96 g)
as a white solid: 1h nmr (d2o, 300 mhz) delta 8.03 (1h, s),
7.87 (1h, s), 7.07 (2h, m), 6.77 (2h, m), 6.57 (1h, t), 5.73
(1h, d), 4.49 (1h, t), 4.18 (1h, m), 4.05 (1h, m), 3.68 (3h,
m), 3.4 (3h, s), 2.74 (2h, m); 31p nmr (d2o, 300 mhz) delta
7.33; hrms (esi) m/z calcd for [m - h]- 546.1508, found
546.1503.
[2-(3-indolyl)-1(s)-(methylcarbamoyl)ethyl]phosphoramidic acid 5â€²-adenosyl ester (2). the yield is 71.9%
(0.31 g) as a white solid: 1h nmr (d2o, 300 mhz) delta 8.07
(1h, s), 7.94 (1h, s), 7.2 (2h, d), 7.12 (2h, d), 6.91 (1h, s),
6.85 (1h, t), 6.65 (1h, t), 5.77 (1h, d), 4.45 (1h, t), 4.13
(1h, t), 4.03 (1h, m), 3.62 (3h, m), 2.49 (3h, s), 1.77 (2h,
m); 31p nmr (d2o, 300 mhz) delta 7.10; hrms (esi) m/z
calcd for [m + h]+ 547.1824, found 547.1851.
[2-(3-indolyl)-1(s)-carbamoylethyl]phosphoramidic acid
5â€²-adenosyl ester (3). the yield is 92% (0.045 g) as a white
solid: 1h nmr (d2o, 300 mhz) delta 7.93 (1h, s), 7.79 (1h,
s), 7.16 (2h, d), 6.99 (2h, d), 6.86 (1h, s), 6.71 (1h, t),
6.55 (1h, t), 5.65 (1h, d), 4.33 (1h, t), 4.03 (1h, t), 3.96
(1h, m), 3.56 (3h, m), 2.78 (2h, m); 31p nmr (d2o, 300
mhz) delta 7.01; hrms (esi) m/z calcd for [m - h]533.1668, found 533.1668.
2(s)-[guanosyl-5â€²-(phosphorylamino)]-3-(3-indolyl)proprionic acid methyl ester (6). the yield is 72% (0.66
g) as a white solid: 1h nmr (d2o, 300 mhz) delta 7.74 (1h,
s), 7.19 (2h, m), 6.91 (2h, m), 6.76 (1h, t), 5.58 (1h, d),
4.49 (1h, m), 4.21 (1h, m), 4.04 (1h, m), 3.72 (3h, m),
3.41 (3h, s), 2.82 (2h, m); 31p nmr (d2o, 300 mhz) delta
7.38; hrms (esi) m/z calcd for [m - h]- 562.1451, found
562.1468.
[2-(3-indolyl)-1(s)-(methylcarbamoyl)ethyl]phosphoramidic acid 5â€²-guanosyl ester (7). the yield is 64.2%
(0.29 g) as a white solid: 1h nmr (d2o, 300 mhz) delta 7.72

phosphoramidate pronucleotides
(1h, s), 7.22 (1h, d), 7.14 (1h, d), 6.86 (2h, m), 6.74 (1h,
m), 5.56 (1h, d), 4.45 (1h, m), 4.12 (1h, m), 3.98 (1h, m),
3.62 (3h, m), 2.83 (2h, m), 2.45 (3h, s); 31p nmr (d2o,
300 mhz) delta 7.38; hrms (esi) m/z calcd for [m + h]+
563.1773, found 563.1813.
[2-(3-indolyl)-1(s)-carbamoylethyl]phosphoramidic acid
5â€²-guanosyl ester (8). the yield is 38.3% (0.21 g) as a white
solid: 1h nmr (d2o, 300 mhz) delta 7.72 (1h, s), 7.28 (1h,
d), 7.15 (1h, d), 6.90 (2h, m), 6.73 (1h, t), 5.56 (1h, d),
4.44 (1h, m), 4.11 (1h, m), 3.96 (1h, m), 3.60 (3h, m),
2.85 (2h, m); 31p nmr (d2o, 300 mhz) delta 7.10; hrms
(esi) m/z calcd for [m - h]- 547.146, found 547.144.
2(r)-[adenosyl-5â€²-(phosphorylamino)]-3-(3-indolyl)proprionic acid methyl ester (11). the yield is 40.1%
(0.31 g) as a white solid: 1h nmr (d2o, 300 mhz) delta 8.16
(1h, s), 7.86 (1h, s), 7.17 (2h, m), 6.93 (1h, t), 6.83 (1h,
s), 6.78 (1h, t), 5.83 (1h, d), 4.20 (1h, t), 4.12 (1h, m),
3.80 (1h, m), 3.70 (2h, m), 3.19 (3h, s), 2.77 (2h, m); 31p
nmr (d2o, 300 mhz) delta 7.36; hrms (esi) m/z calcd for
[m - h]- 546.1508, found 546.1513.
[2-(3-indolyl)-1-ethyl]phosphoramidic acid 5â€²-adenosyl
ester (12). the yield is 37.4% (0.26 g) as a white solid: 1h
nmr (d2o, 300 mhz) delta 7.98 (1h, s), 7.86 (1h, s), 6.99
(2h, m), 6.73 (2h, m), 6.55 (1h, t), 5.7 (1h, d), 4.46 (1h,
m), 4.23 (1h, m), 4.12 (1h, m), 3.78 (2h, m), 2.77 (2h,
m), 2.43 (2h, m); 31p nmr (d2o, 300 mhz) delta 10.25; hrms
(esi) m/z calcd for [m - h]- 488.1447, found 488.148.
[2-(3-indolyl)-1-ethyl]phosphoramidic acid 5â€²-(1-betaarabinofuranosyl)adenine ester (13). the yield is 47%
(0.45 g) as a white solid: 1h nmr (d2o, 300 mhz) delta 8.07
(1h, s), 7.78 (1h, s), 7.11 (1h, d), 7.05 (1h, d), 6.8 (1h, t),
6.75 (1h, s), 6.67 (1h, t), 6.03 (1h, d), 4.43 (1h, m), 4.29
(1h, m), 3.92 (3h, m), 2.80 (2h, m), 2.51 (2h, m); 31p nmr
(d2o, 300 mhz) delta 10.23; hrms (esi) m/z calcd for [m h]- 488.1447, found 488.1422.
2(r)-[guanosyl-5â€²-(phosphorylamino)]-3-(3-indolyl)proprionic acid methyl ester (14). the yield is 16.3%
(0.12 g) as a white solid: 1h nmr (d2o, 300 mhz) delta 7.88
(1h, s), 7.32 (2h, m), 7.08 (1h, m), 6.95 (2h, m), 5.74 (1h,
d), 4.29 (1h, m), 4.14 (1h, m), 3.82 (3h, m), 3.32 (3h, s),
2.90 (2h, m); 31p nmr (d2o, 300 mhz) delta 7.46; hrms
(esi) m/z calcd for [m - h]- 562.1451, found 562.1462.
[2-(3-indolyl)-1-ethyl]phosphoramidic acid 5â€²-guanosyl ester (15). the yield is 16.0% (0.10 g) as a white solid:
1
h nmr (d2o, 300 mhz) delta 7.76 (1h, s), 7.2 (2h, m), 6.98
(1h, m), 6.80 (2h, m), 5.60 (1h, d), 4.27 (1h, m), 4.14 (1h,
m), 3.86 (1h, m), 3.79 (1h, m), 2.85 (2h, m), 2.56 (2h,
m); 31p nmr (d2o, 300 mhz) delta 10.21; hrms (esi) m/z
calcd for [m - h]- 504.1397, found 504.1400.
[2-(3-indolyl)-1-ethyl]phosphoramidic acid 5â€²-(7-benzylguanosyl) ester (16). the reaction mixture was heated
at 55 Â°c for 6 h. the product mixture was concentrated and
the residue chromatographed on silica gel, eluting first with
a chcl3/meoh mixture (80:20) and then with a chcl3/
meoh/h2o mixture (5:3:0.25, containing 0.5% nh4oh).
the solid obtained after evaporation of the solvent was
passed through an ion exchange column (dowex-50w8-200,

articles
na+ form). the yield is 31% (0.04 g) as a white solid: 1h
nmr (d2o, 300 mhz) delta 7.17-7.06 (m, 7h), 6.91 (s, 1h),
6.81 (t, 1h), 6.62 (t, 1h), 5.65 (d, 1h), 4.96 (d, 2h), 4. 25
(t, 1h), 4.15 (d, 1h), 3.96-3.72 (m, 2h), 2.94-2.67 (m,
2h), 2.61 (t, 2h); 31p nmr (d2o, 300 mhz) delta 10.44; hrms
(esi) m/z calcd for [m + h]+ 618.1837, found 618.1825.
[2-(3-indolyl)-1-ethyl]phosphoramidic acid 5â€²-inosyl
ester (17). the yield is 4.5% (0.057 g): 1h nmr (d2o,
300 mhz) delta 8.04 (1h, s), 7.54 (1h, s), 7.14 (2h, m), 6.86
(1h, m), 6.77 (1h, s), 6.69 (1h, m), 5.72 (1h, d), 4.28 (1h,
m), 4.16 (1h, m), 3.87 (1h, m), 3.76 (1h, m), 2.75 (2h,
m), 2.46 (2h, m); 31p nmr (d2o, 300 mhz) delta 10.29; hrms
(esi) m/z calcd for [m - h]- 489.1288, found 489.1279.
[2-(3-indolyl)-1-ethyl]phosphoramidic acid 5â€²-uridyl
ester (18). the yield is 6.3% (0.041 g): 1h nmr (d2o,
300 mhz) delta 7.37 (2h, m), 7.21 (1h, d), 6.97 (2h, m), 6.86
(1h, m), 5.58 (1h, d), 5.18 (1h, d), 3.96 (3h, m), 3.84 (1h,
m), 3.69 (1h, m), 2.95 (2h, m), 2.72 (2h, m); 31p nmr
(d2o, 300 mhz) delta 10.26; hrms (esi) m/z calcd for [m h]- 465.1175, found 465.1174.
[2-(3-indolyl)-1-ethyl]phosphoramidic acid 5â€²-cytidyl
ester (19). the yield is 4.7% (0.031 g): 1h nmr (d2o,
300 mhz) delta 7.42 (1h, d), 7.33 (1h, d), 7.20 (1h, d), 6.94
(2h, m), 6.83 (1h, m), 5.59 (1h, d), 5.35 (1h, d), 3.90 (4h,
m), 3.68 (1h, m), 2.93 (2h, m), 2.7 (2h, m); 31p nmr (d2o,
300 mhz) delta 10.24; hrms (esi) m/z calcd for [m - h]464.1335, found 464.1335.
[2-(3-indolyl)-1-ethyl]phosphoramidic acid 5â€²-thymidyl
ester (20). the yield is 21.9% (0.072 g) as a white solid:
1
h nmr (d2o, 300 mhz) delta 7.24 (1h, d), 7.14 (1h, d), 7.09
(1h, s), 6.92 (2h, m), 6.76 (1h, m), 5.93 (1h, t), 4.26 (1h,
m), 3.89 (1h, m), 3.78 (1h, m), 3.67 (1h, m), 2.9 (2h, m),
2.66 (2h, m), 1.99 (1h, m), 1.82 (1h, m), 1.23 (3h, s); 31p
nmr (d2o, 300 mhz) delta 10.12; hrms (esi) m/z calcd for
[m - h]- 463.1383, found 463.1396.
n-(2-thiono-1,3,2-oxathiaphospholanyl)- l -tryptophan methyl ester (21). n-(2-thiono-1,3,2-oxathiaphospholanyl)-l-tryptophan methyl ester was prepared as previously described with minor modifications.28
to a solution of l-tryptophan methyl ester hydrochloride
(0.25 g, 1 mmol) was added 5 ml of dry pyridine elemental
sulfur (0.07 g, 2 mmol). then 2-chloro-1,3,2-oxathiaphospholane (1 mmol) was added dropwise. the reaction mixture
was stirred at room temperature for 12 h. then the solvent
was removed under reduced pressure; to the residue was
added acetonitrile (10 ml), and an excess of sulfur was
filtered off. after evaporation of the solvent, the residue was
dissolved in 2-3 ml of chloroform and applied to a silica
gel (200-300 mesh) column (2.5 cm Ã— 18 cm). the column
was eluted with chloroform. appropriate fractions were
combined and evaporated under reduced pressure to give the
desired compound as a mixture of diastereoisomers. the
diastereoisomers were separated by crystallization. from the
(28) baraniak, j.; kaczmarek, r.; korczynski, d.; wasilewska, e.
oxathiaphospholane approach to n- and o-phosphorothioylation
of amino acids. j. org. chem. 2002, 67, 7267-7274.
vol. 4, no. 2 molecular pharmaceutics

211

articles
solution of both diastereoisomers in chloroform was deposited the isomer absorbing at lower field in 31p nmr [(cdcl3,
121 mhz) delta 96.54]. mother liquor was concentrated, and
the solid residue was dissolved in the solution of chloroform
and  xxxd2052xxx  (10:1). crystals collected from this solvent
mixture constituted the pure diastereomer resonating in 31p
nmr at higher field [(cdcl3, 121 mhz) delta 95.52]. crystals
of the diastereoisomer absorbing in 31p nmr at lower field
have appeared to be appropriate for x-ray analysis,29 which
proved the existence of the r configuration at the phosphorus
center: yield of 0.27 g (75%); 1h nmr (cdcl3, 300 mhz)
delta 8.09 (bs, 1h), 7.57 (d, 1h), 7.39-7.35 (m, 1h), 7.247.06 (m, 3h), 4.38-4.06 (m, 4h), 3.67 (s, 3h), 3.44-3.26
(m, 4h); 31p nmr (cdcl3, 121 mhz) delta 96.54 (rp), 95.52
(sp); hrfab-ms m/z calcd for [m - h]- 355.0418, found
355.0419.
general procedure for the synthesis of nucleoside 5â€²o-(l-tryptophanylphosphoramidothioates). nucleoside
5â€²-o-(tryptophanylphosphoramidothioates) were prepared by
a similarly described procedure with minor modification.30
the individual diastereoisomer of n-(2-thiono-1,3,2-oxathiaphospholanyl)tryptophan methyl ester (0.36 g, 1 mmol)
was dissolved in dry acetonitrile (5 ml), and into this
solution was dropped a solution of n2-isobutyryl-o2â€²,o3â€²diacetylguanosine (0.44 g, 1 mmol) or n6,o2â€²,o3â€²-tribenzoyladenosine (0.58 g, 1 mmol) and dbu (167 Âµl, 1.1 mmol)
in dry acetonitrile (6 ml). the reaction mixture was stirred
at room temperature for 12 h and then concentrated under
reduced pressure. the residual solid was suspended in 10
ml of 20% aqueous ammonia and left for 24 h at room
temperature in a tightly closed vial. ammonia was then
evaporated; the residue was dissolved in water and purified
on a sephadex a-25 column (3 cm Ã— 20 cm), and products
were eluted with a linear gradient of triethylammonium
bicarbonate buffer (ph 7.5) from 0.05 to 0.4 m. the
appropriate fractions were combined and evaporated to yield
the oily product, which was dissolved in water and passed
through a dowex 50wx2 (na+) column (1.5 cm Ã— 10 cm).
the fractions containing the product were combined and
lyophilized to provide the corresponding products as a
colorless solid.
[2-(3-indolyl)-1(s)-carbamoylethyl]-(sp)-thiophosphoramidic acid 5â€²-adenosyl ester (4). the yield is 71% (0.39
g) as a white solid: 1h nmr (d2o, 300 mhz) delta 8.20 (1h,
s), 8.08 (1h, s), 7.32 (1h, d), 7.12 (1h, d), 7.03 (1h, s),
6.84 (1h, t), 6.67 (1h, t), 5.82 (1h, d), 4.44 (1h, m), 4.12
(2h, m), 3.80 (2h, m), 3.71 (1h, m), 2.97 (2h, m); 31p nmr
(d2o, 121 mhz) delta 55.65; hrfab-ms m/z calcd for [m h]- 547.1954, found 547.1942.
(29) wieczorek, m. unpublished results.
(30) stec, w. j.; grajkowski, a.; karwowski, b.; kobylanska, a.;
koziolkiewicz, m.; misiura, k.; okruszek, a.; wilk, a.; guga,
p.; boczkowska, m. diastereomers of nucleoside 3â€²-o-(2-thio1,3,2-oxathia(selena)phospholanes): building blocks for stereocontrolled synthesis of oligo(nucleoside phosphorothioate)s. j. am.
chem. soc. 1995, 117, 12019-12029.
212

molecular pharmaceutics vol. 4, no. 2

chou et al.
[2-(3-indolyl)-1(s)-carbamoylethyl]-(rp)-thiophosphoramidic acid 5â€²-adenosyl ester (5). the yield is 74.5% (0.41
g) as a white solid: 1h nmr (d2o, 300 mhz) delta 8.28 (1h,
s), 8.06 (1h, s), 7.32 (1h, d), 7.13 (1h, d), 7.02 (1h, s),
6.85 (1h, t), 6.69 (1h, t), 5.82 (1h, d), 4.50 (1h, m), 4.16
(2h, m), 3.94 (1h, m), 3.70 (2h, m), 2.97 (2h, m); 31p nmr
(d2o, 121 mhz) delta 57.96; hrfab-ms m/z calcd for [m h]- 547.1954, found 547.1940.
[2-(3-indolyl)-1(s)-carbamoylethyl]-(sp)-thiophosphoramidic acid 5â€²-guanosyl ester (9). the yield is 76.2% (0.43
g) as a white solid: 1h nmr (d2o, 300 mhz) delta 7. 86 (1h,
s), 7.37 (1h, d), 7.23 (1h, d), 6.96 (2h, t), 6.80 (1h, t),
5.66 (1h, d), 4.52 (1h, m), 4.18 (1h, m), 4.10 (1h, m), 3.86
(2h, m), 3.66 (1h, m), 2.96 (2h, m); 31p nmr (d2o, 121
mhz) delta 55.63; hrfab-ms m/z calcd for [m - h]563.1304, found 543.1236.
[2-(3-indolyl)-1(s)-carbamoylethyl]-(rp)-thiophosphoramidic acid 5â€²-guanosyl ester (10). the yield is 66.5%
(0.38 g) as a white solid: 1h nmr (d2o, 300 mhz) delta 7.
93 (1h, s), 7.39 (1h, d), 7.23 (1h, d), 7.03 (1h, s), 6.97
(1h, t), 6.80 (1h, t), 5.65 (1h, d), 4.58 (1h, m), 4.19 (1h,
m), 4.12 (1h, m), 3.89 (1h, m), 3.76 (2h, m), 2.96 (2h,
m); 31p nmr (d2o, 121 mhz) delta 57.91; hrfab-ms m/z
calcd for [m - h]- 563.1304, found 563.1250.
continuous fluorescent phosphoramidase activity assay. stock solutions of substrates (5 mm) were prepared in
deionized water and filtered through a 0.2 Âµm filter.
hydrolysis of the fluorogenic substrate by hint proteins was
carried out in 600 Âµl of degassed hepes buffer [20 mm
hepes (ph 7.2) and 1 mm mgcl2] in quartz cuvettes at 25
Â°c. the purification of hint proteins has been described
previously.10 fluorescence measurements were taken in a
varian/cary eclipse fluorimeter with the kinetics program
equipped with a thermostated cuvette holder. the excitation
wavelength was set at 280 nm; fluorescence emission was
measured at 360 nm, and excitation and emission slits were
set  xxxd1891xxx  nm for substrate concentrations from 50 nm to 2
Âµm or 5 nm for substrate concentrations from 4 to 50 Âµm.
the fluorescence intensity was monitored for 2 min to obtain
the baseline and allow the temperature to stabilize at 25 Â°c,
and then enzyme was added to initiate the reaction. the
increase in fluorescence intensity was recorded for 2-30 min
on the basis of the rate of hydrolysis. the initial velocities
were obtained by converting the slope of the fluorescence
spectrum into micromolar substrate hydrolyzed per minute,
based on the fluorescence standard curves of substrate and
indole product solutions (figure 1 and tables i and ii of the
supporting information). measurements were carried out in
duplicate, and variants are given as the standard deviation.
equilibrium dialysis. equilibrium dialysis is figured as
a simple but effective tool for the exploration of interactions
between molecules in vitro. the interaction between hhint1
and 3â€²-azido-3â€²- xxxd3364xxx -l-phenylalanine phosphoramidate monoester (l-apo) was analyzed with the equilibrium biodialyzer (the nest group, inc.). hhint1 (0.18 Âµm)
and l-apo (0.1âˆ¼8.6 mm) were loaded into the sample
chamber, and  xxxd3449xxx  [20 mm tris (ph 7.5), 1 mm

articles

phosphoramidate pronucleotides

figure 1. fluorescence assay. the time course was for conversion of the first 10% of the reaction.

edta, and 1 mm dtt] was loaded into the assay chamber.
the concentration of free l-apo at equilibrium was determined by the absorbance at 267 nm. the control was
performed without adding protein.

results and discussion
continuous fluorescence assay development. since the
discovery that hints are nucleoside phosphoramidases, we
have embarked on an effort to map the substrate specificity
of these unique enzymes so that we may better understand
their native function, as well as profit from their potential
as pronucleotide bioactivators. although both hplc-based12
and nmr-based10 assays of hint phosphoramidase activity
have been developed, only two spectrophotometric assays
have been devised. a spectrophotometric assay has been
developed that relies on the release of methylcoumarinamine
from released tert-butoxycarbonyl-l-lysine methylcoumarinamide by trypsin.13 a continuous spectrophotometric assay
that depends on the ability to monitor the release of
p-nitroaniline (410 nm) after hydrolysis of adenosine 5â€²-o
p-nitroaniline phosphoramidate (amp-pna) by hints has
also been developed.27 while each of these spectrophotometric assays has its advantages, the low substrate specificity
(vide supra) for amp-pna and the discontinuous nature and
restriction to lysine-based phosphoramidates of the coumarinbased assay spurred us to investigate the feasibility of
developing a simple, sensitive, and efficient continuous
fluorescence assay that was also structurally flexible enough
to allow the substrate specificity of these enzymes to be
probed in greater detail.
nucleoside phosphoramidates, such as azt l-tryptophan
methyl ester phosphoramidate monoester, that incorporate
the fluorescent indole moiety have been shown to have potent
antiviral and anticancer activity.4 as can be seen in figure
1, because of intramolecular quenching, hydrolysis of the
adenosine tryptophan phosphoramidate (1) by hhint1 can
be easily observed by monitoring the increase in indole
fluorescence with time. due to the magnitude of fluorescence
quenching (>10-fold), this assay can be carried out in the

low micromolar range, while interfilter effects limited the
highest substrate concentration to 50 Âµm.
hint substrate specificity. from an examination of the
michaelis-menten parameters for the series of indolecontaining nucleoside phosphoramidates, a picture of the
substrate specificity for both hhint1 and echint begins to
emerge (tables 1-3). first, on the basis of kcat/km values,
when either adenosine or guanosine phosphoramidateincorporated l-tryptophan, the human enzyme preferred
substitution of the r-carboxylate with a r-carboxamide
(table 1). in contrast, echint exhibited no significant
preference for either the methyl ester, methyl amide, or amide
substitution. this discrepancy is likely due to the closeness
of a h-bond donor in the vicinity of the phosphoramidate
r-carboxylate. this apparently is not the case for echint,
since no particular preference for a substitution at the
r-carboxylate was observed. when the effect of amino acid
stereochemistry was examined, hhint1 was far more sensitive
to configurations at the r-carbon of the amino acid, preferring d- over l-tryptophan by approximately 70- and 120fold for the adenosine and guanosine phosphoramidates,
respectively (table 2). in contrast, the bacterial enzyme
exhibited no particular amino acid stereochemical preference,
thus revealing an additional difference between the active
sites that may be exploited in the development of bacterially
specific pronucleotides. the discrepancy between the enzymes was eliminated with the removal of the r-carboxylate.
tryptamine phosphoramidates of adenosine were shown to
have significantly higher kcat values and lower km values and,
therefore, kcat/km values that are 240-fold (hhint1) and 44fold (echint) greater than the values for  xxxd1794xxx 
phosphoramidates (table 2). obviously, for both enzymes,
the r-carboxylate presents a significant stereochemical
barrier to not only substrate binding but also, on the basis
of the proposed mechanism, formation of the initial adenylated enzyme.
on the basis of the crystal structure of hhint1 with the
stable adp analogue, ampcp, the conserved residues
his112(hhint1) and his101(echint) and his114(hhint1) and
vol. 4, no. 2 molecular pharmaceutics

213

articles

chou et al.

table 1. steady state kinetic comparison of hydrolysis of phosphoramidate and phosphoramidothioate substrates by
hhint1 and echint in hepes buffer (ph 7.2)a

kcat (s-1)
compound
1
2
3
4
5
6
7
8
9
10
a

r1

r2

adenine
adenine
adenine
adenine
adenine
guanine
guanine
guanine
guanine
guanine

ooos- (sp)
s- (rp)
ooos- (sp)
s- (rp)

kcat/km (Ã—10-3 s-1 m-1)

km (Âµm)

r3

hhint1

echint

hhint1

echint

hhint1

echint

och3
nhch3
nh2
nh2
nh2
och3
nhch3
nh2
nh2
nh2

0.012 ( 0.001
0.02 ( 0.003
0.45 ( 0.01
0.011 ( 0.007
0.03 ( 0.008
0.0071 ( 0.002
0.024 ( 0.002
0.23 ( 0.01
0.002 ( 0.0001
0.012 ( 0.003

1.1 ( 0.1
0.52 ( 0.06
1.28 ( 0.09
0.02 ( 0.01
0.07 ( 0.05
0.50 ( 0.02
0.56 ( 0.07
0.52 ( 0.04
0.01 ( 0.003
0.011 ( 0.003

41 ( 4
44 ( 11
50 ( 3
216 ( 15
49 ( 14
31 ( 1
65 ( 9
58 ( 6
52 ( 6
162 ( 23

43 ( 3
63 ( 8
94 ( 9
361 ( 27
779 ( 56
32 ( 3
67 ( 14
64 ( 8
190 ( 66
137 ( 40

0.23 ( 0.04
0.5 ( 0.2
9.2 ( 0.7
0.05 ( 0.04
0.6 ( 0.3
0.23 ( 0.01
0.37 ( 0.08
4.0 ( 0.6
0.04 ( 0.007
0.07 ( 0.03

28 ( 4
8(2
14 ( 2
0.05 ( 0.03
0.09 ( 0.07
16 ( 2
8(3
8(2
0.05 ( 0.03
0.08 ( 0.04

measurements were carried out in duplicate, and variants are given as the standard deviation.

table 2. steady state kinetic parameters of hhint1 and echinta

kcat (s-1)

km (Âµm)

kcat/km (Ã—10-3 s-1 m-1)

compound

r1

r4

r5

r6

hhint1

echint

hhint1

echint

hhint1

echint

1
11
12
13
6
14
15
16
17
18
19
20

adenine
adenine
adenine
adenine
guanine
guanine
guanine
7-benzylguanine
hypoxanthine
uracil
cytosine
thymine

h
h
h
oh
h
h
h
h
h
h
h
h

oh
oh
oh
h
oh
oh
oh
oh
oh
oh
oh
h

s-cooch3
r-cooch3
h
h
s-cooch3
r-cooch3
h
h
h
h
h
h

0.012 ( 0.001
0.27 ( 0.02
2.1 ( 0.1
1.1 ( 0.03
0.0071 ( 0.002
0.26 ( 0.02
2.3 ( 0.07
0.68 ( 0.04
2.6 ( 0.04
2.5 ( 0.3
1.2 ( 0.1
0.10 ( 0.01

1.1 ( 0.1
1.0 ( 0.2
4.5 ( 0.07
1.5 ( 0.4
0.50 ( 0.02
0.37 ( 0.01
4.0 ( 0.4
0.15 ( 0.01
4.2 ( 0.1
2.4 ( 0.6
0.49 ( 0.03
0.02 ( 0.002

41 ( 4
4.1 ( 0.9
0.13 ( 0.02
1.0 ( 0.06
31 ( 1
3.3 ( 0.6
0.21 ( 0.02
14 ( 2
0.71 ( 0.03
2.2 ( 0.4
2.3 ( 0.4
32 ( 5

45 ( 12
45 ( 12
5.2 ( 0.2
60 ( 19
32 ( 3
21 ( 1
6(1
56 ( 6
14 ( 1
42 ( 15
30 ( 3
46 ( 7

0.23 ( 0.04
70 ( 20
15000 ( 3000
1100 ( 100
0.23 ( 0.01
80 ( 30
11000 ( 1000
50 ( 10
3700 ( 300
1200 ( 500
600 ( 200
3(1

28 ( 4
20 ( 10
870 ( 50
30 ( 20
16 ( 2
17 ( 2
700 ( 200
2.6 ( 0.7
310 ( 40
70 ( 60
20 ( 4
0.4 ( 0.2

a

measurements were carried out in duplicate, and variants are given as the standard deviation.

his103(echint) are likely to interact directly with the
phosphorus oxygens and nitrogen of phosphoramidates31
(figure 2). to gain insights into the potential role of these
side chains with the phosphoramidate oxygens, each of the
oxygens of compounds 3 and 8 were stereospecifically
replaced with phosphoramidothioates (table 1). a marked
(31) lima, c. d.; klein, m. g.; hendrickson, w. a. structure-based
analysis of catalysis and substrate definition in the hit protein
family. science 1997, 278, 286-290.
214

molecular pharmaceutics vol. 4, no. 2

decrease in the kcat values for both hhint1 and echint was
observed. the greater effect on kcat observed for both adenosine and guanosine substrates likely reflects the similar importance of specifically aligned active site stabilizing interactions
on both the transition state for either enzyme adenylation or
deadenylation. while the echint km values for the phosphoramidothioates increased, the hhint1 km value was
unchanged for the adenosine rp analogue (4) and the
guanosine sp analogue (9). the idiosyncratic differences

articles

phosphoramidate pronucleotides
table 3. echint/hhint1 ratio of the specificity constant
(kcat/km)
compound

ratio of kcat/km
(echint/hhint1)

compound

ratio of kcat/km
(echint/hhint1)

1
2
3
4
5
6
7
8
9
10

122 ( 39
16 ( 10
1.5 ( 0.3
1(1
0.2 ( 0.2
70 ( 12
22 ( 13
2.0 ( 0.8
1(1
1(1

11
12
13
14
15
16
17
18
19
20

0.3 ( 0.2
0.06 ( 0.01
0.03 ( 0.02
0.21 ( 0.1
0.06 ( 0.02
0.05 ( 0.02
0.08 ( 0.02
0.06 ( 0.07
0.03 ( 0.02
0.13 ( 0.11

observed for these substrates and the hints may reflect subtle
discrepancies in their binding affinity and/or the rate of active
site adenylation by the two enzymes.
probing the hint base recognition site, we determined the
substrate specificity for both purine and pyrimidine phosphoramidates of tryptamine. adenosine (12) and guanosine
(15) phosphoramidates were found to have the greatest kcat/
km values for both enzymes (table 2). indeed, the hhint1
kcat/km value of 1.5 Ã— 107 s-1 m-1 for compound 12 is 30fold greater than the value of 4.9 Ã— 105 s-1 m-1 reported
for the hydrolysis of n--n-boc-lysine adenosine phosphoramidate by the nearly identical rabbit  xxxg1050xxx .27 the slight
preference by hhint1 and echint may be a reflection of a
somewhat tighter set of binding interactions between the
active site and n-3, as well as the ribose ring (figure 3a,b).
evidently, the predicted backbone carbonyl interaction with
2-nh2 (figure 3c) is significant, since the km, and therefore
kcat/km, for tryptamine phosphoramidate of inosine (17) is
3-fold lower than the value for tryptamine guanosine
phosphoramidate (15). neither uridine (18) nor cytidine (19)
phosphoramidates can access either of these backbone
interactions; thus, purine substrates are preferred by both
enzymes, with a uridine analogue enjoying a slight preference
over a cytidine analogue. although the crystal structure
studies demonstrated that n-7 for both adenosine and
guanosine is solvent accessible, the introduction of a benzyl
group at this position seriously compromised both the kcat
and km value and therefore the kcat/km. nevertheless,
modifications on this face are still remarkably well tolerated.
as exhibited by the crystal structure of hhint1 (figure
3), two significant hydrogen bonding interactions are made
with the ribose of either amp or gmp. the inability of either
hhint1 or echint to efficiently hydrolyze thymidine tryptamine
phosphoramidate (20) is consistent with this finding. furthermore, although we were able to demonstrate by equilibrium dialysis that the potent  xxxd3553xxx  phosphoramidate4, l-apo, is able to modestly bind to hhint1 (kd ) 1.0
+ 0.2 mm); l-apo proved neither to be an inbibitor nor a
substrate for hhint1 (chou, t.-f. and wagner, c. r.,
unpublished results). thus, phosphoramidates of dideoxynucleosides are unlikely to be substrates for hints. the
configuration of the substituents at this position is not
absolute, since the ara-a phosphoramidate (13), in which

figure 2. x-ray crystallographic structure of hhint1 with
bound ampcp (a) (pdb entry 1av5) and of the hhint1 active
site with bound amp (b) (pdb entry 1kpf; ref 31).

the 2â€²-oh group is in the opposite beta-configuration, is
tolerated as a substrate (table 2).
summary and concluding remarks. on the basis of
these results, a general outline of the phosphoramidase
substrate specificity requirements for hints can be delineated.
first, although there is a clear preference for purine phosphoramidates, pyrimidine-based phosphoramidates can be
considered as viable substrates. second, on the basis of
crystal structure studies and our kinetic results with phosphoramidothioates, substitutions of the phosphoramidate
oxygens are not likely to be tolerated. third, regardless of
the base, maintenance of an electrophilic or hydrogenbonding group at the ribose 2â€²-position is essential. phosphoramidates containing deoxy- or dideoxynucleosides, such
as d4t and azt, therefore, are not likely to be substrates
for mammalian hints.2,4,5,7 nevertheless, as the results with
ara-a demonstrate, the beta-configuration is well tolerated,
opening the door to the potential for drugs such as  xxxd2120xxx ,32,33  xxxd1722xxx ,34  xxxd1790xxx ,35,36 and the recently discovered
2â€²-methyl nucleosides37 to be substrates for hints. fourth,
phosphoramidates containing a primary amine with as few
as two methylene groups are significantly favored as
substrates over sterically crowded amines. the remarkable
vol. 4, no. 2 molecular pharmaceutics

215

articles

chou et al.
expanded by improving their cellular uptake, as well as by
incorporation of an additional tissue targeting compound or
synergistic drug coupled through an alkyl amine linker.
last, although the phosphoramidase activity of hints has
only recently been discovered, it has been known for decades
that both bacterial and mammalian tissues express a  xxxd2246xxx  phosphoramidase. smith and burrow were the
first to demonstrate this activity, when they discovered that
e. coli extracts were able to efficiently hydrolyze adenosine
phosphoramidate (amp-nh2).40 shabarova and co-workers
later partially purified a phosphoramidase from rabbit and
rat liver extracts that specifically preferred to hydrolyze
phosphoramidate-containing purine bases and d-amino acids.41 the first phosphoramidase purified to homogenenity
was obtained from bacterial extracts by kumon and coworkers and shown to be a 28 kda homodimer.42 unfortunately, since they did not obtain sequence data for this
protein, its identity could not be determined. consequently,
on the basis of our substrate specificity results for both
bacterial and human hints, we believe that the identity of
the phosphoramidase previously studied is eukaryotic  xxxg1050xxx 
and prokaryotic hint. nevertheless, given the inability of
hhint1 to hydrolyze l-apo or the related antiviral analog,
3â€²-azido-3â€²- xxxd3364xxx -l-tryptophan methyl amide phosphoramidate (chou, t.-f. and wagner, c. r., unpublished
results), it is highly unlikely that the phosphoramidase

figure 3. hydrogen bonding network surrounding the purine
ring and ribose of amp-bound hhint1 (a) (pdb entry 1kpf;
ref 31) and ribose gmp-bound rabbit  xxxg1050xxx  (b) (pdb entry
3rhn; ref 43), revealing the chemical basis of discrimination
by hhint1 of ara-adenosine, guanosine, and inosine as
substrates.

efficiency with which hints can convert nucleoside phosphoramidates to the 5â€²-monophosphates is comparable to the
values of 103-106 observed for nucleoside kinases, such as
adenosine kinases.38,39 one can envision, therefore, that the
therapeutic utility of nucleoside phosphoramidates could be
(32) brockman, r. w.; schabel, f. m., jr.; montgomery, j. a. biologic
activity of  xxxd2120xxx , a metabolically
stable analog of 9-beta-d-arabinofuranosyladenine. biochem. pharmacol. 1977, 26, 2193-2196.
(33) danhauser, l.; plunkett, w.; keating, m.; cabanillas, f. 9-beta-darabinofuranosyl-2-fluoroadenine 5â€²-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed
leukemia and lymphoma. cancer chemother. pharmacol. 1986,
18, 145-152.
(34) lindemalm, s.; liliemark, j.; gruber, a.; eriksson, s.; karlsson,
m. o.; wang, y.; albertioni, f. comparison of cytotoxicity of
2-chloro-2â€²-arabino-fluoro-2â€²-deoxyadenosine ( xxxd1722xxx ) with
cladribine in mononuclear cells from patients with acute myeloid
and chronic lymphocytic leukemia. haematologica 2003, 88,
324-332.
216

molecular pharmaceutics vol. 4, no. 2

(35) kufe, d. w.; major, p. p.; egan, e. m.; beardsley, g. p.
correlation of cytotoxicity with incorporation of  xxxd1790xxx  into dna.
j. biol. chem. 1980, 255, 8997-9000.
(36) major, p. p.; egan, e. m.; beardsley, g. p.; minden, m. d.; kufe,
d. w. lethality of human myeloblasts correlates with the
incorporation of  xxxd1790xxx  into dna. proc. natl.
acad. sci. u.s.a. 1981, 78, 3235-3239.
(37) eldrup, a. b.; allerson, c. r.; bennett, c. f.; bera, s.; bhat, b.;
bhat, n.; bosserman, m. r.; brooks, j.; burlein, c.; carroll, s.
s.; cook, p. d.; getty, k. l.; maccoss, m.; mcmasters, d. r.;
olsen, d. b.; prakash, t. p.; prhavc, m.; song, q.; tomassini, j.
e.; xia, j. structure-activity relationship of purine ribonucleosides
for inhibition of hepatitis c virus rna-dependent rna polymerase. j. med. chem. 2004, 47, 2283-2295.
(38) maj, m. c.; singh, b.; gupta, r. s. pentavalent ions dependency
is a conserved property of  xxxg79xxx  from diverse
sources: identification of a novel motif implicated in phosphate
and  xxxd2531xxx  binding and substrate inhibition. biochemistry
2002, 41, 4059-4069.
(39) darling, j. a.; sullivan, w. j.; carter, d.; ulman, b.; roos, d.
s. recombinant expression, purification, and characterization of
toxoplasma gondii  xxxg79xxx . mol. biol. parasitol. 1999,
103, 15-23.
(40) smith, r. a.; burrow, d. j. enzymic cleavage of phosphoramidic
acid. biochim. biophys. acta 1959, 34, 274-276.
(41) shabarova, z. a. synthetic nucleotide-peptides. prog. nucleic acid
res. mol. biol. 1970, 10, 145-182.
(42) kuba, m.; okizaki, t.; ohmori, h.; kumon, a. nucleoside
monophosphoramidate hydrolase from rat liver: purification and
characterization. int. j. biochem. 1994, 26, 235-245.
(43) brenner, c.; garrison, p.; gilmour, j.; peisach, d.; ringe, d.;
petsko, g. a.; lowenstein, j. m. crystal structures of hint
demonstrate that histidine triad proteins are gadt-related nucleotide-binding proteins. nat. struct. biol. 1997, 4, 231-238.

articles

phosphoramidate pronucleotides
activity responsible for the activation of the previously
reported  xxxd3553xxx  and d4t phosphoramidates is
hhint1.2,4,5,7 the identity of this enzyme(s) remains to be
determined.

abbreviations used
echint, e. coli histidine triad nucleotide binding protein;
hhint1, human  xxxg1050xxx ;
amp-lysine, amp-n--(n-r-acetyllysine methyl ester) 5â€²phosphoramidate; ampcp, adenosine 5â€²-(r,beta-methylene)diphosphate; gmp, guanosine 5â€²-monophosphate; dtt,
dithiothreitol; edta, ethylenediaminetetraacetic acid; hit,
histidine triad; sds-page, sodium dodecyl sulfatepolyacrylamide gel electrophoresis; tris, tris(hydroxymethyl)aminomethane.

acknowledgment. we thank dr. phalguni ghosh for
technical assistance and for providing a sample of 7-benzylguanosine monophosphate. we thank dr. w. stec (polish
academy of sciences) for stimulating discussions. we
gratefully acknowledge the national institutes of health
(hl073719 and hl076779) and the university of minnesota
academic health center for partial support of this research.
supporting information available: fluorescence
standard curves (figure 1), fluorescence factors obtained
from fluorescence standard curves in hepes buffer (table
i), and equations used to convert fluorescence intensity
changes to velocities (table ii). this material is available
free of charge via the internet at http://pubs.acs.org.
mp060070y

vol. 4, no. 2 molecular pharmaceutics

217

